Crossmark

Current status of CAR-T cell therapy for pediatric hematologic malignancies

Crossref DOI link: https://doi.org/10.1007/s10147-023-02346-6

Published Online: 2023-05-08

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hiramatsu, Hidefumi https://orcid.org/0000-0003-3136-5670
License Information

Text and Data Mining valid from 2023-05-08

Version of Record valid from 2023-05-08
More Information

Article History

Received: 9 March 2023

Accepted: 18 April 2023

First Online: 8 May 2023

Declarations

:

: The author declares no potential conflicts of interest.